2024-08-19
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
Interface News Reporter |
Interface News Editor | Jiang Yiman
Since the Central Financial Work Conference clearly proposed to "do a good job in the five major areas of science and technology finance, green finance, inclusive finance, pension finance, and digital finance", various financial institutions have resonated with each other and displayed their strengths.
How can the water be so clear? Only the source of fresh water. As the first of the "five major articles", where does the fresh water of science and technology finance come from? Recently, a reporter from Jiemian News found in a survey that although technology companies still have the pain points and difficulties of "not understanding and not seeing through" and "not daring to lend and invest", some banking institutions have built a long-term, three-dimensional and diversified science and technology financial ecosystem in financial services, abandoned the traditional ideas of asset mortgage or legal person guarantee, and provided technology companies with precise services throughout the life cycle, injecting financial fresh water into the fertile soil of technological innovation.
At the same time, the amount of loan funds is not a single evaluation indicator. Each technology company has different conditions and endowments. In cooperation with banks, technology companies can only thrive under the infiltration of financial "living water" if they obtain financial products that truly match their own development stage.
When start-up technology companies are racing ahead, they adjust their development direction according to the market environment, and their demand for funds is both urgent and fleeting. From the perspective of traditional banks' credit granting ideas, such companies are often easily blind spots in services.
Kuoran Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as Kuoran Biotechnology) is such a specialized and innovative enterprise that focuses on the translational research and application of precision medicine for tumors. While providing testing services to more than 500 hospitals and scientific research institutions across the country, it plans to promote the company's independently developed and produced next-generation pathology equipment based on multiple fluorescent immunohistochemistry technology to more hospitals, allowing doctors to complete testing in hospitals and making the diagnostic process more efficient.
In an interview, Bu Lingbin, chairman of Kuoran Bio, said that in recent years, the company's largest investment has been in R&D funds. In view of the current economic situation and capital market environment, the company has demonstrated a high degree of strategic flexibility and responsibility, and decided to fine-tune the current project portfolio, focusing precious resources on products that have obtained medical device registration licenses or are about to obtain licenses in the clinical stage, thereby bringing the company stable cash flow and initial market influence.
In the second half of 2023, as the company's scale expanded and the demand for office space increased, Kuoran Bio moved to Pujiang International Life Science City in Minhang District, Shanghai, and launched its independently developed next-generation integrated pathology solution, covering a full set of instruments, reagents and software for self-developed tumor microenvironment detection, from fully automatic fluorescent staining, fully automatic quantitative pathology imaging to pathology image analysis software.
Shanghai Branch of Shanghai Pudong Development Bank quickly caught up with Kuoran Bio's capital demand and provided the company with a "Puxin Loan" product, lending 5 million yuan. According to reports, "Puxin Loan" is a working capital loan product for small and medium-sized enterprises with scientific and technological innovation qualifications, providing qualified enterprises with working capital for daily operating turnover.
During the cooperation, Bu Lingbin was impressed by the in-depth understanding and research of the biopharmaceutical industry by the account managers of Shanghai Pudong Development Bank, their strong industry expertise and sensitivity, and the loan products they recommended were very suitable for the development cycle of enterprises. Moreover, they were online loans with short loan periods and could be repaid at any time, without the need to withdraw money offline. This not only supplemented the operating funds, but also supported the business development at a lower cost of funds.
Fang Yijing, deputy president of Zhangjiang Science and Technology Branch of Shanghai Branch of Pudong Development Bank, said that banking services are not just a simple loan, but more about providing corresponding services based on the needs of enterprises at different stages. Science and technology enterprises usually have the characteristics of high R&D investment, rapid technological iteration and great market uncertainty, and their income and profitability often show volatility. Therefore, the traditional banking idea of relying solely on asset mortgage or corporate guarantee is abandoned, and more emphasis is placed on a comprehensive understanding of enterprises and in-depth insights into industry development.
This is a microcosm of Pudong Development Bank's service to Shanghai's science and technology enterprises. As of the end of March 2024, the bank's Shanghai branch served about 12,000 technology companies, serving more than 90% of the companies listed on the Science and Technology Innovation Board in Shanghai, and the scale of technology loans exceeded 100 billion yuan.
Credit loans of millions or tens of millions can be a "godsend" for a start-up company, but for science and technology companies that have entered the development track and want to cross the cycle, during the peak period of R&D investment and temporarily poor operating cash flow, the demand for unsecured loan funds reaches hundreds of millions. How can banks judge whether they have good growth potential?
tripodKang ShengIt is a world-leading contract development and manufacturing services (CDMO) company, selected as a "potential unicorn enterprise in China", a "pilot platform for the transformation of scientific and technological achievements" in Wuhan, and a "gazelle enterprise in Optical Valley". The industry it is in is both highly R&D-intensive and greatly affected by the "scale effect".
After restructuring and operating independently in 2020, DingKang ShengThings are in a critical period of transformation.
According to DingKang ShengWei Jianzhong, president of Wu, introduced that at that time the company was in urgent need of increasing its market share in the CDMO field, but the industry characteristics of delayed customer payments and uncertain account terms required it to prepare sufficient funds to cope with daily operations and emergencies.
On the other hand, the global CDMO market has reached hundreds of billions and is still in a period of rapid growth. According to the characteristics of the industry, in order to ensure the profitability and market competitiveness of enterprises, it is necessary to plan and build sufficient production capacity in advance according to market demand. Wei Jianzhong said that in this process, we should not only pay attention to the current order volume, but also predict the market trends and customer needs in the next few years, so as to formulate a reasonable capacity expansion plan.
At that time, many banks still used the risk concept of mortgage as king to conduct credit business. At this juncture, Pudong Development Bank Wuhan Branch broke the convention and provided it with a credit loan of 90 million yuan to solve its working capital needs.
According to Tian Ye, general manager of the Technology Finance Department of Shanghai Pudong Development Bank Wuhan Branch, this is a result of an in-depth investigation of DingKang ShengThis 90 million yuan loan was the largest credit loan given by Wuhan Branch to R&D enterprises at that time. This move also prompted other banks to start paying attention to DingKang ShengTogether, we help businesses grow.
This has laid a foundation of trust for further cooperation between the two parties.Kang ShengThe production capacity of the Phase I plant could not meet the business needs at the time, so we planned to start the construction of the Phase II project ahead of schedule, expand production, and comprehensively upgrade process research and development and production technology.
After learning about the company's project construction plan, Shanghai Pudong Development Bank Wuhan Branch introduced the relevant policies on interest subsidies for equipment renovation and transformation loans issued by the National Development and Reform Commission to the company, and combined with the policies, customized financial service plans for the company and provided 250 million yuan in financial support. The loan was included in the interest subsidy catalog, allowing the company to enjoy policy benefits.
It is worth noting that when this loan was issued, it was not fully collateralized because the company's equipment had not yet arrived. However, the CDMO industry has its own particularities, and most of the equipment is imported and customized, and the time of arrival is uncertain.
According to Tan Lina, deputy president of Pudong Development Bank Wuhan Dongxihu Branch, after continuous communication between the head office and branches, there was no rigid requirement to mortgage equipment as a prerequisite. Based on the actual business needs of the enterprise, the bank tailored withdrawal conditions and financing period plans to meet the needs of the enterprise.
It is based on this professional judgment thatKang ShengOnly scientific and technological enterprises like Wuwu can enjoy better financial services. At present, Shanghai Pudong Development Bank Wuhan Branch has become DingKang ShengThe preferred cooperative bank for goods. As of the end of March 2024, Shanghai Pudong Development Bank Wuhan Branch has served more than 1,700 technology-based enterprises, with a technology loan balance of more than 17 billion yuan, and has served more than 240 specialized and innovative "little giants" enterprises, with a service coverage rate of more than 35%, and has served more than 600 provincial-level specialized and innovative enterprises, with a service coverage rate of nearly 20%.
During their research, Interface News reporters found that in order to flexibly meet the diverse needs of technology-based companies at different stages, banks are building a long-term, three-dimensional, and diversified technology finance ecosystem.
For example, relying on the technology and financial ecosystem resources accumulated by the bank over the years, we have widely introduced partners from various fields such as government, industry, academia, research, and finance to pave the "first kilometer" of innovation and entrepreneurship for technology companies and open up the "last kilometer" of transformation of scientific and technological achievements. Through full life cycle services, we accompany companies in their growth.
At the same time, the bank's talent pool is also facing new and higher requirements.
Whether it is Kuoran Biology or DingKang ShengWhen it comes to cooperation with banks, the word "professional" is indispensable. For an industry like biomedicine, which is somewhat difficult for the general public, what a company does, how well it does it, and whether it has development potential all put forward higher requirements on the professional capabilities of banks. Looking at more high-tech industries such as integrated circuits and chips, they all require bankers to become "industry experts."
From the perspective of the enterprise, only when a bank staff has a full understanding of the enterprise can he have a better and more in-depth dialogue with the founder, make a better judgment on the enterprise's funding needs, and achieve a high degree of match between funding supply and the enterprise's R&D needs.
Therefore, many banks have begun to cultivate a special team of "industry experts", such as assigning reviewers to specific industries and recruiting high-quality talents from specific industries into the bank's team.
Collect and organize the latest news information and make it available for free for everyone to read
